PropertyValue
is ?:annotates of
?:creator
?:journal
  • European_Neuropsychopharmacology
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • P.508 COVID-19 impact on entry symptom severity in schizophrenia clinical trials – preliminary data
?:type
?:who_covidence_id
  • #933049
?:year
  • 2020

Metadata

Anon_0  
expand all